Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Nexra Wins Additional Near-Term Contract in Taiwan
-
Mitch Gould Reflects on Chuck Norris Legacy Following Passing of Martial Arts Icon
-
Santos Muscle Nutrition Preparing for OneLavi Launch in the United States
-
NYC Blepharoplasty Surgery Practice Reports Rising Demand for Eyelid Surgery Among Men
-
Basys.ai Partners with ePathUSA Prime Contractor on AI-Enabled Medical Record Review for CMS
-
KPM Analytics Expands NexaFlo® Continuous Flow Platform for Seawater Nutrient Analysis
-
Zero Networks Launches Kubernetes Access Matrix to Reduce Blast Radius at Scale
-
General Availability of Dapr Agents Delivers Production Reliability for Enterprise AI
-
Latent-Y: The Autonomous AI Agent for Drug Design at Scale
-
Wolters Kluwer launches Genya Dichiarativi with embedded AI to support Italian tax and accounting professionals
-
OpenSSF Celebrates New Members, No-Cost Tooling, and Project Milestones
-
OpenObserve Expands Global Cloud Footprint in North America and Europe
-
Rakovina Therapeutics to Present New Data at the AACR Annual Meeting 2026 – World’s Premier Cancer Research Forum
-
Hankook's iON Race Supports Competitive Racing at Historic Madrid E-Prix
-
Fluke Launches Next-Generation RotAlign Core and Elite Laser Shaft Alignment Solutions
-
Share repurchase programme: Transactions of week 12 2026
-
Share buyback programme – week 12
-
New data on long-term, real-world treatment with lecanemab presented at the 2026 AD/PD™ congress
-
Danone to acquire Huel, extending its portfolio in Functional Nutrition
-
Roblon launches new Group strategy and presents financial ambitions towards 2030
-
AB Akola Group will buy-back its own shares
-
Global Bags and Luggage Market to Grow at a CAGR of 2.15% Through 2032, Driven by Travel Recovery and Everyday Utility Demand, Says Reports Vyansa Intelligence
-
Morphy Richards Wins Award at AWE 2026, Unveils New Kitchen Appliances
-
Invitation to presentation of Essity's interim report for quarter 1, 2026
-
GAM Alternatives Fund managers call on Liontrust Asset Management to commence immediate strategic review
-
Bakery China 2026 to Kick Off in Shanghai in May, Spotlighting Global Innovations for the Baking Industry
-
Nebius Group Announces Closing of Private Offering of Convertible Senior Notes, With Aggregate Gross Proceeds of Approximately $4.3 Billion
-
European Technical Raises the Bar for Property Maintenance Services Across Dubai
-
Veolia Drives the Czech Coal Exit with a Multi-Energy Transformation in Karviná
-
Data on debtor composition
-
Empire Metals Limited Announces Final Results
-
InterContinental Hotels Group PLC Announces Transaction in Own Shares - March 23
-
Preliminary data on early redemptions (prepayments)
-
Hexagon publishes the Annual Report and Sustainability Report 2025
-
Just - Evotec Biologics Enters Project Agreement with BARDA to Optimize Biomanufacturing of Antibodies Against Ebola and Related Viruses
-
APEMARS Stage 12 at $0.000125 Ends in 24 Hours: The Next Big Meme Coin After Dogecoin and Axie Infinity – Hurry or Miss Out
-
Claranova and Reverso Enter Into a Strategic Partnership and Launch an AI-Native Multilingual Document Intelligence Platform for Businesses
-
Almirall's 17th Skin Academy Highlights Scientific Advances in Inflammatory Skin Diseases and Skin Cancer, Patient-Reported Outcomes, and Holistic Care in Medical Dermatology
-
Impact Senior Living Expands in South Carolina with Addition of The Colonnade at West Ashley
-
Annual figures 2025: BNG supports the Dutch public sector during a year full of major investment challenges
-
Bridging The Gap: "All Access With Andy Garcia" To Showcase On Point Strategy's Success In Turning Grants Into Community Result
-
Prosafe SE: Operational update – February 2026
-
Groundbreaking Danish research project launches to cure Parkinson’s disease
-
Persica Pharmaceuticals Appoints Dr Edward Littler as Executive Chairman and David Watson as Chief Executive Officer
-
OSB GROUP PLC - Transaction in Own Shares
-
NBPE Announces Transaction in Own Shares
-
Amphista Therapeutics announces three presentations at the American Association for Cancer Research Annual Meeting on its next-generation Targeted Glue™ degrader programs
-
ABRIDGED, PRELIMINARY AND UNAUDITED QUARTERLY AND FULL YEAR RESULTS AND DETAILS OF MANAGEMENT CONFERENCE Call for the Fourth Quarter and Full Year Ended December 31, 2025 ("The Quarter" or "Q4 2025" a
-
Zluri Expands Platform to Deliver Identity Security for the Modern Enterprise
-
Sensorion Reports Six-Month Update from the Audiogene Phase 1/2 Trial of SENS-501 and Advances GJB2-GT (SENS-601) Toward First-in-Human Clinical Development

